Enhancing NICU Safety with Medsafe-AI's Precision Medication

Medsafe-AI, funded through the Government of Western Australia’s Innovation Booster Grant, is dedicated to reducing 10-fold dosing errors and improving medication safety in neonatal intensive care units. The AI-driven platform continuously validates prescriptions against clinical guidelines, patient weight, age, and condition to ensure every dose is accurate and appropriate. By proactively identifying potential errors before they occur, Medsafe-AI strengthens clinician confidence, minimizes risk, and safeguards the lives of vulnerable newborns.

Real-Time Prescription Validation
MedsafeAI continuously validates prescriptions against clinical guidelines, patient weight, age, and condition. This ensures that every dose is precise and appropriate, minimizing the risk of medication errors.
AI-Driven Error Detection
Our AI-driven platform acts as a silent safety net, alerting clinicians to potential errors before they reach the bedside. This proactive approach reduces the risk of overdoses, underdoses, and harmful interactions.
Seamless Workflow Integration
MedsafeAI integrates seamlessly into existing hospital workflows, acting as a silent safety net that alerts clinicians to potential errors. This ensures minimal disruption and maximum efficiency in daily operations.

Medsafe-AI is now a spin-off company